BioSpace News Archive

Due to technical improvements in surgery, an increase in the number of surgical cases, and a rise in the incidence of cardiac problems and uterine fibroids, the need for insufflation devices is rising.

Edentulism, whether full or partial, considerably impact the quality of life of the individual. The negative impacts span across aesthetic, psychological, and functional aspects, led by the difficulty in speech and hindrance in proper eating patterns.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per the latest Fact.MR analysis, the ultra-low temperature freezers market is expected to reach US$ 509.09 Mn in 2021.

Virtual care refers to a technique that allows for the treatment of patients dealing with different health issues with the help of advanced technologies such as audio, video, or written communication.

The Transportable Exam Backpack is a lightweight, mobile telehealth station offered by GlobalMed, an international provider of virtual health solutions.

RepliCel Life Sciences Inc., a company developing next-generation technologies in aesthetics and orthopedics, provided an update on its dermal injector program.

The Medicines Patent Pool and Merck, known as MSD outside the United States and Canada, announced the signing of a voluntary licensing agreement to facilitate affordable global access for molnupiravir, an investigational oral COVID-19 antiviral medicine for the treatment of mild-to-moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization.

Immunic, Inc., a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced enrollment of the first psoriasis patient in Part C of its ongoing phase 1 clinical trial of IMU-935, a highly potent and selective inverse agonist of the transcription factor RORγt.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that it will release its third quarter 2021 financial results on Wednesday, November 3, 2021, before the markets open.

China and the USA predicted to lead innovation by 2030 in an age of mass personalized therapeutics, cobots, AI, and automation delivering process improvements.